Here are relevant reports on : human-resource-technology-market
-
Single Cell Analysis Market By Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2029
The global single-cell analysis market, valued at US$3.41B in 2023, is forecasted to grow at a 13.6% CAGR, reaching US$3.67B by 2024 and US$6.95B by 2029. Growth of the single-cell analysis market can be attributed to factors such as the rising incidences of cancer and immunological disorders, technological developments in single-cell analysis products, growing focus on advancement of stem cell research, and increasing focus on advancement of biotechnology sector.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Eye Tracking Market by Offering (Hardware, Software, Services), Tracking Type (Remote and Mobile), Application (Assistive Communication, and Human Behavior & Market Research), Vertical, and Geography- Global Forecast to 2025
The Eye Tracking Market is expected to grow from USD 368 million in 2020 to USD 1,098 million by 2025, at a CAGR of 24.5% during the forecast period. A few key players operating in the eye tracking market are Tobii (Sweden), EyeTracking (US), SR Research (Canada), Seeing Machines (Australia), PRS IN VIVO (France), Smart Eye (Sweden), EyeTech Digital Systems (US), Eyegaze (US), Ergoneers (Germany), ISCAN (US), iMotions (Denmark), and Lumen Research (UK).
- Published: July 2020
- Price: $ 4950
- TOC Available:
-
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), ROA (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Vaccine (Human, Veterinary (Companion, Livestock)), Type (Organic, Inorganic) - Global Forecast to 2029
The global vaccine adjuvants market, valued at US$0.66B in 2023, is forecasted to grow at a 6.5% CAGR, reaching US$0.70B by 2024 and US$0.96B by 2029. Growing awareness about livestock health, increasing the adoption of companion animals and developing of therapeutic vaccines for cancer, allergies, and autoimmune disorders are creating lucrative growth opportunities
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Swarm Intelligence Market by Model, Capability (Clustering, Routing, Scheduling, and Optimization), Application (Robotics, Drones, and Human Swarming), and Geography - Global Forecast to 2030
The swarm intelligence market is expected to be valued at USD 447.2 Million by 2030, growing at a CAGR of 40.47% from 2020 to 2030, considering the technology will get commercialized by 2020. The estimated year considered for the study is 2020, and the forecast period is between 2020 and 2023. The report profiles the most promising players in this market. The key players in this market are DoBots (Netherlands), Hydromea (Switzerland), Sentien Robotics (US), Unanimous A.I. (US), AxonAI (US), Swarm Technology (US), SSI Schäfer - Fritz Schäfer (Germany), Valutico (Austria), Enswarm (UK), and Power-Blox (Switzerland).
- Published: November 2017
- Price: $ 4950
- TOC Available:
-
Fish Oil Market for Aquaculture, Direct Human Consumption, Hydrogenation & Industrial Applications - Industry Analysis, Size, Share, Growth, Trends & Forecast, 2012 - 2018
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Defense Electronics Obsolescence Market by System (Communication System; Navigation System; Human Machine Interface; Flight Control System; Targeting System; Electronic Warfare System; and Sensors), Type & Region - Global Forecast to 2028
The defense electronics obsolescence market is expected to grow from USD 2.5 billion in 2023 to USD 3.7 billion by 2028, at a compound annual growth rate (CAGR) of 8.2% during the forecast period.The key players Raytheon Technologies Corporation (US), BAE Systems (UK), L3Harris Technologies, Inc. (US), Thales (US) and Elbit Systems Ltd. (Israel).
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Monoclonal Antibody Therapeutics Market / mABs Therapeutics Market Size by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
The global monoclonal antibody therapeutics market, valued at US$222.6B in 2023, is forecasted to grow at a 14.5% CAGR, reaching US$252.6B by 2024 and US$497.5B by 2029. Driving factors of the market, including clinical trials, encompass increasing prevalence of complex diseases, advancements in biotechnology facilitating targeted treatments, regulatory support expediting approval processes, and robust investments in research and development. Clinical trials play a pivotal role in validating efficacy, safety, and commercial viability, driving market growth.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Wealth Management Platform Market by Advisory Model (Human Advisory, Robo Advisory, and Hybrid), Business Function (Reporting, Portfolio, Accounting, and Trading Management), Deployment Model, End-User Industry, and Region - Global Forecast to 2022
The global wealth management platform market size is expected to grow from USD 1.70 Billion in 2017 to USD 3.20 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period. The wealth management platform ecosystem comprises vendors, such as SS&C Technologies, Inc. (US), Fiserv, Inc. (US), Fidelity National Information Services (US), Profile Software (UK), Broadridge Financial Solutions, Inc. (US), InvestEdge, Inc. (US), Temenos Group AG (Switzerland), Finantix S.p.A. (Italy), SEI Investments Company (US), Comarch SA (Poland), Objectway S.p.A. (Italy), and Dorsum Ltd. (Hungary). The other stakeholders of the wealth management platform market include managed service providers, third-party providers, and technology providers.
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Industrial Software Market by Type (Manufacturing Execution System, SCADA, Human Machine Interface, Robotic Software, Fault Detection and Classification, Al in manufacturing, Industrial Metrology), End-use (Process, Discrete) - Global Forecast to 2029
The global industrial software market is expected to grow from USD 21.5 billion in 2024 to USD 46.6 billion by 2029, at a compound annual growth rate (CAGR) of 16.7 % during the forecast period.The key players Siemens (Germany), Rockwell Automation (US), ABB (Switzerland), Emerson Electric Co. (US) and General Electric (US).
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Primary Cells Market by Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Pharma Biotech, CROs, Academia), Region - Global Forecast to 2028
The global primary cells market, valued at US$1.5B in 2022, is forecasted to grow at a 10.5% CAGR, reaching US$1.7B by 2023 and US$2.8B by 2028. The growth of this market can be attributed to factors such as the is the growing advantages of primary human cells over cell lines, rising growth in pharmaceutical & biotechnology industries, increasing demand for monoclonal antibodies, Government investments for cell-based research, and increasing cancer research.
- Published: July 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
